Overview: hormone refractory prostate cancer
- 1 December 1999
- Vol. 54 (6) , 1-7
- https://doi.org/10.1016/s0090-4295(99)00447-1
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Bilateral Orchiectomy with or without Flutamide for Metastatic Prostate CancerNew England Journal of Medicine, 1998
- An adjustment to the 1997 estimate for new prostate cancer cases.CA: A Cancer Journal for Clinicians, 1997
- Cancer statistics, 1997CA: A Cancer Journal for Clinicians, 1997
- Combined androgen blockade for the treatment of metastatic cancer of the prostateUrology, 1996
- Maximum androgen blockade in advanced prostate cancer: an overview of 22 randomised trials with 3283 deaths in 5710 patientsThe Lancet, 1995
- Some statistical considerations for the interpretation of trials of combined androgen therapyCancer, 1993
- Stage D1 prostate cancer treated by radical prostatectomy and adjuvant hormonal treatment. Evidence for favorable survival in patients with DNA diploid tumorsCancer, 1992
- The Value of Testosterone Deprivation in Stage D1 Carcinoma of the ProstateJournal of Urology, 1988
- Combination therapy with flutamide and castration (LHRH agonist or orchiectomy) in advanced prostate cancer: A marked improvement in response and survivalJournal of Steroid Biochemistry, 1985
- The timing of androgen ablation therapy and/or chemotherapy in the treatment of prostatic cancerThe Prostate, 1984